聚合酵素鏈鎖反應(PCR) 市場規模、佔有率及成長分析（按類型、產品、適應症、最終用戶和地區）－2025 年至 2032 年產業預測

聚合酵素鏈鎖反應(PCR) 市場規模預計在 2023 年達到 101 億美元，並從 2024 年的 109.5 億美元成長到 2032 年的 208.7 億美元，預測期內（2025-2032 年）的複合年成長率為 8.4%。

近年來，全球聚合酵素鏈鎖反應(PCR) 市場經歷了顯著成長，因為它已成為分子生物學和診斷領域的關鍵技術。這種多功能方法對於 DNA 和 RNA 樣本的擴增和分析至關重要，可應用於研究、臨床診斷、法醫學和生物技術。市場擴張的主要促進因素包括感染疾病率上升、個人化醫療的需求、基因組學的進步以及對快速準確診斷的需求，尤其是在 COVID-19 大流行之後。市場上有許多領先的公司提供各種 PCR 工具、耗材和服務。傳統技術正在轉向更有效率、自動化的解決方案，如即時PCR和數位 PCR，從而提供更高的速度和靈敏度。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

聚合酵素鏈鎖反應（PCR）市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 標準PCR
• 即時PCR
• 數位PCR

聚合酵素鏈鎖反應（PCR）市場規模（依產品及複合年成長率）（2025-2032）

• 市場概覽
• 裝置
• 試劑和耗材

聚合酵素鏈鎖反應（PCR）市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概覽
• 感染疾病
• 腫瘤學
• 遺傳性疾病
• 其他

聚合酵素鏈鎖反應（PCR）市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院和診所
• 製藥和生物技術產業
• 診斷中心
• 學術和研究機構

聚合酵素鏈鎖反應（PCR）市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Agilent Technologies（USA）
• Thermo Fisher Scientific（USA）
• Siemens Healthineers（Germany）
• bioMerieux（France）
• Becton, Dickinson and Company（USA）
• Bio-Rad Laboratories（USA）
• Merck KGaA（Germany）
• PerkinElmer（USA）
• Promega Corporation（USA）
• Danaher Corporation（USA）
• QIAGEN（Netherlands）
• QuantuMDx Group Ltd（UK）
• Eppendorf（Germany）
• Fluidigm Corporation（USA）
• Microsynth AG（Switzerland）
• JN Medsys（Singapore）
• Takara Bio Inc（Japan）

結論和建議

Polymerase Chain Reaction (PCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.95 billion in 2024 to USD 20.87 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global polymerase chain reaction (PCR) market has seen remarkable growth recently, emerging as a crucial technology in molecular biology and diagnostics. This versatile method, essential for amplifying and analyzing DNA and RNA samples, finds applications across research, clinical diagnostics, forensics, and biotechnology. Key drivers of market expansion include rising rates of infectious diseases, the demand for personalized medicine, advancements in genomics, and the necessity for rapid, accurate diagnostics, particularly in the aftermath of the COVID-19 pandemic. The market boasts numerous leading players offering a diverse array of PCR tools, consumables, and services. Traditional techniques are shifting towards more efficient, automated solutions like real-time and digital PCR, enhancing speed and sensitivity, while portable devices broaden access to point-of-care applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Polymerase Chain Reaction (PCR) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Polymerase Chain Reaction (PCR) Market Segments Analysis

Global Polymerase Chain Reaction (PCR) Market is segmented by Type, Product, Indication, End User and region. Based on Type, the market is segmented into Standard PCR, Real-time PCR and Digital PCR. Based on Product, the market is segmented into Instruments and Reagents & Consumables. Based on Indication, the market is segmented into Infectious Diseases, Oncology, Genetic Disorders and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers and Academic & Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market is significantly influenced by its widespread application in molecular diagnostics for the detection and monitoring of various diseases, including infectious diseases, cancers, and genetic disorders. The COVID-19 pandemic has notably heightened the need for accurate and rapid diagnostic tools, leading to an increased demand for PCR-based tests and diagnostics. This trend is expected to persist, further propelling the growth of the PCR market as healthcare providers and laboratories seek reliable solutions to facilitate timely diagnosis and effective patient management in the face of evolving health challenges.

Restraints in the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market faces significant challenges due to the high costs associated with PCR units and consumables. This financial burden poses a substantial barrier for smaller laboratories, clinics, and research institutions that may struggle to afford the necessary equipment and materials. As a result, the limited accessibility of PCR technology in resource-constrained environments restricts its adoption and utilization, which could hinder overall market growth, particularly in developing regions where healthcare budgets are often tight. Addressing these economic constraints is crucial for expanding PCR applications and fostering advancements in diagnostic and research capabilities.

Market Trends of the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market is witnessing a significant trend towards Point-of-Care (POC) PCR testing solutions, fueled by the growing need for rapid and on-site diagnostic capabilities, particularly highlighted during the COVID-19 pandemic. Healthcare providers are increasingly prioritizing quick results, which are crucial for managing infectious disease outbreaks and improving patient outcomes. The surge in demand for convenient testing options has led to a proliferation of POC PCR devices and kits, enhancing accessibility for healthcare facilities and patients alike. This shift not only streamlines the diagnostic process but also positions the POC PCR segment as a key driver of market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Polymerase Chain Reaction (PCR) Market Size by Type & CAGR (2025-2032)

• Market Overview
• Standard PCR
• Real-time PCR
• Digital PCR

Global Polymerase Chain Reaction (PCR) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Consumables

Global Polymerase Chain Reaction (PCR) Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

Global Polymerase Chain Reaction (PCR) Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Industries
• Diagnostic Centers
• Academic & Research Organizations

Global Polymerase Chain Reaction (PCR) Market Size & CAGR (2025-2032)

• North America (Type, Product, Indication, End User)
  • US
  • Canada
• Europe (Type, Product, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsynth AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations